1,1-Bis(3 ′ -indolyl)-1-( p -bromophenyl)methane and Related Compounds Repress Survivin and Decrease γ -Radiation-Induced Survivin in Colon and Pancreatic Cancer Cells

1,1-Bis(3 ′ -indolyl)-1-( p -bromophenyl)methane (DIM-C-pPhBr) and the 2,2 ′ -dimethyl analog (2,2 ′ -diMeDIM-C-pPhBr) inhibit proliferation and induce apoptosis in SW480 colon and Panc28 pancreatic cancer cells. In this study, treatment with 10–20 μ M concentrations of these compounds for 24 hr induced cleaved PARP and decreased survivin protein and mRNA expression in both cell lines. However, results of time course studies show that DIM-C-pPhBr and 2,2 ′ -diMeDIM-C-pPhBr decrease survivin protein within 2 hr after treatment, whereas survivin mRNA levels were decreased only at later time points indicating activation of transcription-independent and -dependent pathways for downregulation of survivin. In addition, we also observed that γ -radiation inhibited pancreatic and colon cancer cell growth and this was associated with enhanced expression of survivin after 24 (SW480) or 24 and 48 (Panc28) hr and correlated with previous studies on the role of survivin in radiation-resistance. However, in cells cotreated with γ -radiation plus DIM-C-pPhBr or 2,2 ′ -diMeDIM-C-pPhBr, induction of survivin by γ -radiation was inhibited after cotreatment with both compounds, suggesting applications for these drugs in combination cancer chemotherapy with γ radiation.

[1]  S. Safe,et al.  Enhancement of Docetaxel Anticancer Activity by a Novel Diindolylmethane Compound in Human Non–Small Cell Lung Cancer , 2009, Clinical Cancer Research.

[2]  S. Safe,et al.  Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3′-indoly)-1-(p-substituted phenyl)methanes , 2008, Molecular Cancer Therapeutics.

[3]  S. Safe,et al.  Curcumin decreases specificity protein expression in bladder cancer cells. , 2008, Cancer research.

[4]  M. Abdelrahim,et al.  1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase. , 2008, Carcinogenesis.

[5]  Fengzhi Li,et al.  Survivin repression by p53, Rb and E2F2 in normal human melanocytes. , 2008, Carcinogenesis.

[6]  S. Safe,et al.  1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways , 2008, Breast Cancer Research and Treatment.

[7]  Y. Lotan,et al.  Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder. , 2007, Urology.

[8]  J. Cleveland,et al.  Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels. , 2007, Cancer research.

[9]  N. Tsuji,et al.  Survivin Down-regulation Plays a Crucial Role in 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor-induced Apoptosis in Cancer* , 2007, Journal of Biological Chemistry.

[10]  W. Mann,et al.  Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. , 2007, Cancer research.

[11]  N. Zaffaroni,et al.  Targeting survivin in cancer therapy: fulfilled promises and open questions. , 2007, Carcinogenesis.

[12]  R. Walker,et al.  Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients , 2007, British Journal of Cancer.

[13]  S. Pradhan,et al.  Molecular Mechanisms of Transactivation and Doxorubicin-mediated Repression of survivin Gene in Cancer Cells* , 2007, Journal of Biological Chemistry.

[14]  B. Aggarwal,et al.  γ-Tocotrienol Inhibits Nuclear Factor-κB Signaling Pathway through Inhibition of Receptor-interacting Protein and TAK1 Leading to Suppression of Antiapoptotic Gene Products and Potentiation of Apoptosis* , 2007, Journal of Biological Chemistry.

[15]  Y. Lotan,et al.  Survivin expression is associated with bladder cancer presence, stage, progression, and mortality. , 2006, Cancer.

[16]  D. Altieri The case for survivin as a regulator of microtubule dynamics and cell-death decisions. , 2006, Current opinion in cell biology.

[17]  R. Medema,et al.  The case for Survivin as mitotic regulator. , 2006, Current opinion in cell biology.

[18]  Lily Yang,et al.  KLF5 Interacts with p53 in Regulating Survivin Expression in Acute Lymphoblastic Leukemia* , 2006, Journal of Biological Chemistry.

[19]  J. Uddin,et al.  Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo , 2006, Molecular Cancer.

[20]  Sudhakar Chintharlapalli,et al.  1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARγ-dependent and PPARγ-independent pathways , 2006, Molecular Cancer Therapeutics.

[21]  Zhiwei Wang,et al.  Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. , 2006, Cancer research.

[22]  M. Abdelrahim,et al.  Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists. , 2006, Cancer research.

[23]  Mutsushi Yamasaki,et al.  Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells. , 2005, Oncology reports.

[24]  A. Wickrema,et al.  Differential requirements for survivin in hematopoietic cell development. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Hatano,et al.  Transcriptional activation of survivin through the NF‐κB pathway by human T‐cell leukemia virus type I tax , 2005, International journal of cancer.

[26]  K. Yoon,et al.  Activation of Nur77 by Selected 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes Induces Apoptosis through Nuclear Pathways* , 2005, Journal of Biological Chemistry.

[27]  C. Rödel,et al.  Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. , 2005, Cancer research.

[28]  A. Chakravarti,et al.  Survivin mediates resistance to antiandrogen therapy in prostate cancer , 2005, Oncogene.

[29]  N. Zaffaroni,et al.  Survivin as a target for new anticancer interventions , 2005, Journal of cellular and molecular medicine.

[30]  Fengzhi Li,et al.  Molecular Mechanism of Inhibition of Survivin Transcription by the GC-rich Sequence-selective DNA Binding Antitumor Agent, Hedamycin , 2005, Journal of Biological Chemistry.

[31]  Fengzhi Li,et al.  Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines , 2005, Oncogene.

[32]  Fengzhi Li,et al.  Induction of Survivin Expression by Taxol (Paclitaxel) Is an Early Event, Which Is Independent of Taxol-mediated G2/M Arrest* , 2004, Journal of Biological Chemistry.

[33]  A. Winoto,et al.  Essential Role of Survivin, an Inhibitor of Apoptosis Protein, in T Cell Development, Maturation, and Homeostasis , 2004, The Journal of experimental medicine.

[34]  Lily Yang,et al.  Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. , 2003, Cancer research.

[35]  S. Chiou,et al.  Survivin expression in the stomach: implications for mucosal integrity and protection. , 2003, Biochemical and biophysical research communications.

[36]  Zvi Fuks,et al.  Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.

[37]  C. Rödel,et al.  Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor. , 2003, International journal of radiation oncology, biology, physics.

[38]  K. Shiraki,et al.  Expression of survivin during liver regeneration. , 2002, Biochemical and biophysical research communications.

[39]  M. Daidone,et al.  Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer , 2002, Cellular and Molecular Life Sciences CMLS.

[40]  Naoki Watanabe,et al.  Survivin as a Radioresistance Factor in Pancreatic Cancer , 2000, Japanese journal of cancer research : Gann.

[41]  F. Sigaux,et al.  Expression and prognostic significance of survivin in de novo acute myeloid leukaemia , 2000, British journal of haematology.

[42]  J Diebold,et al.  Prognostic significance of survivin expression in diffuse large B-cell lymphomas. , 2000, Blood.

[43]  D. Altieri,et al.  Transcriptional analysis of human survivin gene expression. , 1999, The Biochemical journal.

[44]  J C Reed,et al.  IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.